Alcon AG | ALC - Selling And Administration Expenses


Alcon AG reported $882M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
AstraZeneca USD 5.8B 735M Jun/2026
Bayer EUR 3.7B 356M Mar/2026
Essilor EUR 5.75B 139M Jun/2026
Fresenius EUR 760M 17M Jun/2026
Fresenius Medical Care EUR 749M 36M Mar/2026
GlaxoSmithKline GBP 2.19B 75M Jun/2026
GRIFOLS EUR 289M 8M Jun/2026
Merck EUR 1.52B 80M Mar/2026
Novartis USD 3.24B 101M Jun/2026
Philips EUR 1.21B 23M Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
Sanofi EUR 2.63B 307M Jun/2026
Smith & Nephew USD 1.45B 29M Jun/2026
Sonova Holding CHF 880.2M 300K Jun/2025
UCB EUR 1.47B 193M Dec/2025